5H-Indazol-5-one, 2,4,6,7-tetrahydro-2-methyl-, 98%, 250mg

Mortiers 55 bruts, 700 ml, Hauteur, 70 mm, 1 Pièce

Ethyl 4-(4-n-Propylphenyl)-4-oxobutanoate, 97.0%, 5g

(S)-1-(Tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amine, 95.0%, 1g

1,4-Benzenedimethanethiol>98.0%(GC)5g

BENZYL (3-FLUORO-4-THIOMORPHOLINOPHENYL)CARBAMATE, 95.0%, 1g

METHYL 5-BROMO-3-(BROMOMETHYL)PICOLINATE, 95.0%, 5g

5-Chloro-3-methylpicolinaldehyde, 97%, 1g

(2S)-3-methyl-2-(N-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)butanoic acid, 97%, 1g

1H,1H-Heptafluorobutyl acrylate, 95.0%, 25g

6-Chloro-1H-pyrrolo[2,3-b]pyridine-4-carbonitrile, 95.0%, 1g

Flacons de réaction ROTILABO®, 1,5 ml, noir, non stérile, 500 pièce(s)

Isopropyl 2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-alpha-D-glucopyranoside, 50mg